General Information of the Compound
| Compound ID |
CP0489773
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-ethyl-1H-benzo[d]imidazol-2(3H)-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-EB10
1-EBIO
1-Ethyl-2-benzimidazolinone
1-Ethyl-Benzimidazolinone
1-Ethylbenzimidazolin-2-one
1-Ethylbenzimidazolinone
1-ethyl-1,3-dihydro-2h-benzimidazol-2-one
1-ethyl-1,3-dihydrobenzimidazol-2-one
1-ethyl-1H-benzo[d]imidazol-2(3H)-one
1-ethyl-2,3-dihydro-1H-1,3-benzodiazol-2-one
10045-45-1
2H-Benzimidazol-2-one, 1-ethyl-1,3-dihydro-
3-ethyl-1H-benzimidazol-2-one
AC1Q2ZX3
AC1Q2ZX4
CHEBI:34076
CHEMBL452887
CXUCKELNYMZTRT-UHFFFAOYSA-N
EBIO
EINECS 233-148-1
M82W79SS4W
Tocris-1041
UNII-M82W79SS4W
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H10N2O
|
||||||||||||||||||
| Molecular Weight |
162.192
|
||||||||||||||||||
| Canonical SMILES |
CCn1c2ccccc2[nH]c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H10N2O/c1-2-11-8-6-4-3-5-7(8)10-9(11)12/h3-6H,2H2,1H3,(H,10,12)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CXUCKELNYMZTRT-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
10045-45-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound